erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the .
"we know that hdl, the good cholesterol, is low in psoriasis, but here, we now show that despite reduction in systemic .